{"altmetric_id":1317296,"counts":{"readers":{"mendeley":39,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Kieran_Neuro"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa63c3cf058f610008ecf","authors":["Mizuno, Yoshikuni","Kondo, Tomoyoshi"],"doi":"10.1002\/mds.25418","endpage":"1141","first_seen_on":"2013-03-23T12:59:04+00:00","issns":["1531-8257"],"issue":"8","journal":"Movement Disorders","last_mentioned_on":1364043374,"links":["http:\/\/onlinelibrary.wiley.com\/resolve\/doi?DOI=10.1002%2Fmds.25418"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mds.25418\/pdf","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Human Movement And Sports Science","scheme":"era"},{"name":"Cognitive Science","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"startpage":"1138","subjects":["neurology"],"title":"Adenosine A2A receptor antagonist istradefylline reduces daily off time in Parkinson's disease","type":"article","volume":"28","mendeley_url":"http:\/\/www.mendeley.com\/research\/adenosine-a2a-receptor-antagonist-istradefylline-reduces-daily-time-parkinsons-disease"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":3632408,"mean":4.9240837059336,"rank":2740317,"this_scored_higher_than_pct":20,"this_scored_higher_than":734327,"rank_type":"exact","sample_size":3632408,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":85865,"mean":6.3319359219232,"rank":60479,"this_scored_higher_than_pct":23,"this_scored_higher_than":20031,"rank_type":"exact","sample_size":85865,"percentile":23},"this_journal":{"total_number_of_other_articles":1331,"mean":2.5933308270677,"rank":984,"this_scored_higher_than_pct":17,"this_scored_higher_than":227,"rank_type":"exact","sample_size":1331,"percentile":17},"similar_age_this_journal_3m":{"total_number_of_other_articles":7,"mean":1.0833333333333,"rank":5,"this_scored_higher_than_pct":28,"this_scored_higher_than":2,"rank_type":"exact","sample_size":7,"percentile":28}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":1,"Librarian":1,"Researcher":7,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":4,"Student  > Postgraduate":3,"Student  > Master":8,"Other":3,"Student  > Bachelor":8},"by_discipline":{"Engineering":1,"Medicine and Dentistry":18,"Neuroscience":4,"Chemistry":1,"Sports and Recreations":1,"Psychology":1,"Agricultural and Biological Sciences":6,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":4,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"GB":1},"mendeley":{"US":1,"JP":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/Kieran_Neuro\/status\/315446890466512896","citation_ids":[1317296],"posted_on":"2013-03-23T12:56:14+00:00","author":{"name":"Kieran Breen","url":"http:\/\/www.linkedin.com\/in\/kcbreen","image":"https:\/\/pbs.twimg.com\/profile_images\/835168863637495808\/oPq0DFKU_normal.jpg","description":"Director of Research at Brain Tumour Research - all views are my own","id_on_source":"Kieran_Neuro","tweeter_id":"35511598","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1011},"tweet_id":"315446890466512896"}]}}